Literature DB >> 25838080

Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.

Mikinao Oiwa1, Tokiko Endo, Shu Ichihara, Suzuko Moritani, Masaki Hasegawa, Akari Iwakoshi, Yasuyuki Sato, Takako Morita, Takako Hayashi, Aya Kato.   

Abstract

Breast cancer is occasionally complicated by sclerosing adenosis (SA). Although both lesions usually originate in the terminal duct lobular unit, their pathogenetic relationship has not yet been elucidated. The present study analyzed 63 breast cancer patients with SA (involving a total of 75 breasts) to clarify if coexisting SA increased the frequency of multicentric breast cancer or not. Using the topographical classification proposed in our previous study, breast cancers with SA were classified into the following three types: type A (n = 22), cancer area was completely surrounded by the SA; type B (n = 26), cancer area partially overlapped the SA; and type C (n = 27), cancer area was located separate from the SA. Breast cancers with SA had a significant (P < 0.001) increase in frequency of harboring bilateral and multicentric cancers [17 of 63 (27%) and 15 of 63 (24%), respectively] when compared to breast cancer patients without SA, regardless of topographical type. Breast cancers with SA were less invasive (P < 0.001), of lower histological grade (P = 0.034), and had similar frequency of estrogen receptor-positive (P = 0.21) and HER2-positive (P = 0.74) tumors. In conclusion, contralateral and ipsilateral multicentric breast cancers occurred at a higher frequency in those with SA. Our data suggest that SA is, in addition to lobular neoplasia, a predictor of multicentric breast cancers.

Entities:  

Mesh:

Year:  2015        PMID: 25838080     DOI: 10.1007/s00428-015-1769-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes.

Authors:  Alan M Nichol; Rinat Yerushalmi; Scott Tyldesley; Mary Lesperance; Chris D Bajdik; Caroline Speers; Karen A Gelmon; Ivo A Olivotto
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

2.  Invasive breast cancer risk in women with sclerosing adenosis.

Authors:  R A Jensen; D L Page; W D Dupont; L W Rogers
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

3.  Abnormal regulation of the oestrogen receptor in benign breast lesions.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; C Munro; M P Davies; D R Sibson; J P Sloane
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

4.  Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.

Authors:  Suzuko Moritani; Shu Ichihara; Masaki Hasegawa; Tokiko Endo; Mikinao Oiwa; Misaki Shiraiwa; Chikako Nishida; Takako Morita; Yasuyuki Sato; Takako Hayashi; Aya Kato; Hideaki Aoyama; Kazuaki Yoshikawa
Journal:  Histopathology       Date:  2011-03-14       Impact factor: 5.087

5.  Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy.

Authors:  Füsun Taşkin; Kutsi Köseoğlu; Alparslan Unsal; Muhan Erkuş; Serdar Ozbaş; Can Karaman
Journal:  Diagn Interv Radiol       Date:  2011-02-15       Impact factor: 2.630

6.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

7.  Intraductal carcinoma of the breast arising in sclerosing adenosis.

Authors:  S Ichihara; H Aoyama
Journal:  Pathol Int       Date:  1994-09       Impact factor: 2.534

8.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

9.  Benign breast lesions mimicking carcinoma at mammography.

Authors:  S Pojchamarnwiputh; M Muttarak; W Na-Chiangmai; B Chaiwun
Journal:  Singapore Med J       Date:  2007-10       Impact factor: 1.858

10.  A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors.

Authors:  Jia-Jian Chen; Yan Wang; Jing-Yan Xue; Ying Chen; Ya-Ling Chen; Qin Xiao; Wen-Tao Yang; Zhi-Min Shao; Jiong Wu
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more
  1 in total

1.  Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population.

Authors:  Naisi Huang; Jiajian Chen; Jingyan Xue; Baohua Yu; Yanqiong Chen; Wentao Yang; Zhimin Shao; Jiong Wu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.